-+ 0.00%
-+ 0.00%
-+ 0.00%

Evommune Q4 EPS $(1.43) Misses $(0.74) Estimate

Benzinga·03/05/2026 21:05:24
Listen to the news
Evommune (NYSE:EVMN) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(0.74) by 91.95 percent. This is a 89.47 percent increase over losses of $(13.58) per share from the same period last year.